The Relationship Between Lower Extremity Selective Motor Control and Gait in Children With Cerebral Palsy

September 11, 2023 updated by: Erkan Erol, Tokat Gaziosmanpasa University
The aim of this study is to examine the relationship between lower extremity selectivity and gait in children with cerebral palsy. 32 volunteer children with CP between the ages of 5-20 will participate in the study. The Selective Control Assessment of the Lower Extremity (SCALE) questionnaire will be used to assess lower extremity selectivity, and the Edinburgh observational gait scale will be used to assess gait. Both assessments are observational.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Tokat, Turkey, 60250
        • Recruiting
        • Faculty of Health Sciences, Tokat Gaziosmanpaşa University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Cerebral palsy

Description

Inclusion Criteria:

  • Between the ages of 5-20
  • Diagnosed with CP

Exclusion Criteria:

  • Medical complications that limit participation in assessments (for example, severe visual impairment)
  • Lower extremity surgery or botox surgery in the last 6 months
  • Mental problems that cannot understand the commands given

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Edinburgh Visual Gait Score
Time Frame: Baseline
It consists of 17 items scored separately for the right and left lower extremities. Assessments include 6 anatomical levels: trunk, pelvis, hip, knee, ankle, and foot. These anatomical levels are evaluated in the sagittal, coronal and transverse planes. A 3-point ordinal scale is used for scoring. In scoring, a value of 0 indicates normal, a value of 1 indicates moderate deviation from normal, and a value of 2 indicates significant deviation from normal. The scores obtained by watching the camera recordings for each lower extremity are summed and a single score is obtained.
Baseline
Selective Control Assessment of the Lower Extremity (SCALE)
Time Frame: Baseline
Evaluates the selective motor control of the lower extremities. It evaluates hip, knee, ankle, subtalar and finger joints bilaterally. Voluntary flexion and extension movements are observed to assess selective voluntary motor control at each joint. Except for the hip joint, which is tested in the side-lying position to allow adequate joint movement, the evaluation of other joints is made in the sitting position.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Tokat Gaziosmanpasa University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2023

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

July 30, 2024

Study Registration Dates

First Submitted

February 19, 2023

First Submitted That Met QC Criteria

February 19, 2023

First Posted (Actual)

March 1, 2023

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GaziosmanpasaU_Erol_05

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe